Synbiotic Treatment in Crohn's Disease Patients

Clinical Trial ID NCT00305409

Rank	Title	Journal	Year	PubWeight™‹?›
1	European evidence based consensus on the diagnosis and management of Crohn's disease: current management.	Gut	2006	3.59
2	European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis.	Gut	2006	3.57
3	Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial.	Gut	2005	2.29
4	European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.	Gut	2006	1.87
5	Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study.	Gut	2004	1.85
6	Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health?	BMJ	1999	1.65
7	Identification and quantitation of mucosal and faecal desulfovibrios using real time polymerase chain reaction.	Gut	2004	1.63
8	Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria.	Clin Infect Dis	2004	1.43
9	Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response.	Gut	2004	1.26